N-5-Carboxypentyl-deoxymannojirimycin (CAS 104154-10-1)

N-5-Carboxypentyl-deoxymannojirimycin, a derivative of the iminosugar deoxymannojirimycin, has garnered significant interest in glycobiology and enzymology research. Its mechanism of action primarily involves inhibition of glycosidases, particularly α-mannosidases, by mimicking the transition state of the substrate. By binding to the active site of these enzymes, it interferes with the hydrolysis of glycosidic bonds, leading to the accumulation of misfolded glycoproteins within cells. This accumulation triggers the unfolded protein response (UPR), a cellular stress response pathway, and ultimately induces endoplasmic reticulum (ER) stress-mediated apoptosis. Researchers have utilized this compound to investigate the role of glycosidases in various biological processes, including protein folding, quality control, and ER-associated degradation (ERAD). Moreover, N-5-Carboxypentyl-deoxymannojirimycin has been instrumental in elucidating the molecular mechanisms underlying lysosomal storage disorders (LSDs), where impaired glycosidase activity results in the accumulation of undegraded glycolipids or glycoproteins within lysosomes. Additionally, this compound shows promise as a potential agent for LSDs and other glycosylation-related disorders by modulating glycosidase activity and restoring cellular homeostasis. Overall, N-5-Carboxypentyl-deoxymannojirimycin represents a valuable tool in glycoscience research, offering insights into glycosidase function and potential interventions for related disorders.